DaTscan: Clinical Trials

2 trials of DaTscan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Withdrawn 1

Follow DaTscan: new trials by email Literature Review of DaTscan trials Research Report on DaTscan

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
NAV5001, DaTscan - Parkinson's Syndrome
Phase 3WithdrawnNavidea Biopharmaceuticals2017-04-012017-09-13
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
DatSCAN - Lewy Body Dementia, Non-DLB Dementia
Phase 3CompletedGE Healthcare3262003-11-012007-05-16

Conditions studied

Dementia, Vascular (1)  ·  Lewy Body Disease (1)  ·  Parkinson Disease (1)

Sponsors

GE Healthcare (1)  ·  Navidea Biopharmaceuticals (1)

Countries

Germany (1)  ·  United States (1)

Top investigators

Cornelia Reininger, M.D. Ph.D. (1)  ·  Marc Pignot, PhD (1)

Results publications

PMID 24993764